Literature DB >> 26364000

[Risk factors associated with leg erysipelas (cellulitis) in sub-Saharan Africa: A multicentre case-control study].

P Pitché1, B Diatta2, O Faye3, B-F Diané4, A Sangaré5, P Niamba6, C Mandengue7, L Kobengue8, B Saka9, A Diop2, F Ly2, M-T Dieng2, A Dicko3, M-M Soumah4, M Cissé4, S-H Kourouma5, Y-I Kouassi5, T Boukari9, S Akakpo9, K Tchangaï-Walla9.   

Abstract

BACKGROUND: Acute bacterial cellulitis of the leg (erysipelas) is a common problem involving considerable morbidity in dermatology practice in Africa. Previous studies conducted in Europe and North Africa have highlighted lymphoedema and toe-web intertrigo as independent factors associated with leg erysipelas. The aim of this case-control study was to identify risk factors associated with leg erysipelas in sub-Saharan Africa, within a different socio-economic and culture context. PATIENTS AND METHODS: We conducted a prospective case-control study in hospital dermatology departments in 8 sub-Saharan African countries over a 12-month period (October 2013 to September 2014). Each case of acute leg cellulitis was matched with 2 controls for age (±5 years) and sex. We analysed the general and local factors.
RESULTS: During the study period, 364 cases (223 female, 141 male) were matched with 728 controls. The mean age was 42.15±15.15 years for patients and 42.11±36 years for controls. Multivariate analysis showed the following to be independent risk factors associated with leg erysipelas in our study: obesity (odds ratio [OR]=2.82 ; 95% confidence interval: 2.11-3.76), lymphoedema (OR=3.87, 95%CI: 2.17-6.89), voluntary cosmetic depigmentation (OR=4.29, 95%CI: 2.35-7.83), neglected traumatic wound (OR=37.2, 95%CI: 24.9-57.72) and toe-web intertrigo (OR=37.86, 95%CI: 22.27-64.5).
CONCLUSION: The results of this study confirms the major role of local risk factors (toe-web intertrigo, lymphoedema) previously identified in other geographical settings. However, the originality of our study consists of the identification of voluntary cosmetic depigmentation as a risk factor for leg erysipelas in sub-Saharan Africa.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Afrique subsaharienne; Cosmetic depigmentation; Dépigmentation volontaire; Facteurs de risque; Intertrigo; Leg erysipela; Lymphoedema; Lymphœdème; Risk factors; Sub-Saharan Africa; Érysipèle de jambe

Mesh:

Year:  2015        PMID: 26364000     DOI: 10.1016/j.annder.2015.08.003

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  6 in total

1.  Methodology Series Module 2: Case-control Studies.

Authors:  Maninder Singh Setia
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

2.  Risk factors of lower limb cellulitis in a level-two healthcare facility in Cameroon: a case-control study.

Authors:  Tsi Njim; Leopold Ndemnge Aminde; Valirie Ndip Agbor; Louise Daniele Toukam; Sara Saheb Kashaf; Eric O Ohuma
Journal:  BMC Infect Dis       Date:  2017-06-12       Impact factor: 3.090

3.  Risk factors and complications of lower limb cellulitis in Africa: a systematic review.

Authors:  Frank-Leonel Tianyi; Clarence Mvalo Mbanga; Celestin Danwang; Valirie Ndip Agbor
Journal:  BMJ Open       Date:  2018-07-23       Impact factor: 2.692

4.  Factors associated with acute and recurrent erysipelas in a young population: a retrospective of 147 cases.

Authors:  Amal Chamli; Kahena Jaber; Imene Ben Lagha; Malek Ben Slimane; Faten Rabhi; Nejib Doss; Mohamed Raouf Dhaoui
Journal:  Tunis Med       Date:  2021 Aout

5.  [Evaluation of general practitioners' knowledge about diagnostic and therapeuthic management of erysipelas in the city of Marrakech].

Authors:  Fatima Ihbibane; Ntini Lebi Arsène; Latifa Adarmouch; Mohamed Amine; Noura Tassi
Journal:  Pan Afr Med J       Date:  2018-01-17

6.  Morbidity diagnosed in an internal medicine department of a secondary care center (Msaken, Sousse, Tunisia).

Authors:  Mohamed Khelil; Chokri Zoghlami; Imen Horrigue; Dhekra Chebil; Sarra Nouira; Abdelhamid Ben Lakhal; Ahmed Ben Abdelaziz
Journal:  Tunis Med       Date:  2021-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.